Pear Therapeutics | 8-K: Current report
Pear Therapeutics | 8-K: Current report
Pear Therapeutics | 8-K: Current report
Pear Therapeutics | 8-K: Current report
Pear Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Pear Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Pear Therapeutics | 8-K: Current report
Pear Therapeutics | S-3: Registration statement for specified transactions by certain issuers
PEAR THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Pear Therapeutics Reports Third Quarter 2022 Results
PEAR THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Pear Therapeutics Reports Second Quarter 2022 Results
Pear Therapeutics | 8-K: Current report
Pear Therapeutics | 8-K: Current report
Pear Therapeutics | 8-K: Current report
Pear Therapeutics | 8-K: Current report
PEAR THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Pear Therapeutics Reports First Quarter 2022 Financial Results
Pear Therapeutics | 8-K: Current report
Pear Therapeutics | DEFA14A: Others
Pear Therapeutics | DEF 14A: Definitive proxy statements
Pear Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
PEAR THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K/A: Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
No Data